BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 29607531)

  • 1. Vancomycin-induced acute kidney injury in elderly Chinese patients: a single-centre cross-sectional study.
    Pan KM; Wu Y; Chen C; Chen ZZ; Xu JA; Cao L; Xu Q; Wu W; Dai PF; Li XY; Lv QZ
    Br J Clin Pharmacol; 2018 Aug; 84(8):1706-1718. PubMed ID: 29607531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vancomycin-associated acute kidney injury: A cross-sectional study from a single center in China.
    Pan K; Ma L; Xiang Q; Li X; Li H; Zhou Y; Yang L; Cui Y
    PLoS One; 2017; 12(4):e0175688. PubMed ID: 28426688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of Acute Kidney Injury Among Patients Receiving the Combination of Vancomycin with Piperacillin-Tazobactam or Meropenem.
    Robertson AD; Li C; Hammond DA; Dickey TA
    Pharmacotherapy; 2018 Dec; 38(12):1184-1193. PubMed ID: 30175410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Intra-Operative Topical Vancomycin and the Incidence of Acute Kidney Injury.
    Blackman AL; Joshi M; Doub J; Seung H; Banoub M; Claeys KC; Heil EL
    Surg Infect (Larchmt); 2021 Oct; 22(8):810-817. PubMed ID: 33571051
    [No Abstract]   [Full Text] [Related]  

  • 5. Establishment of an AUC
    Chavada R; Ghosh N; Sandaradura I; Maley M; Van Hal SJ
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephrotoxicity of piperacillin/tazobactam combined with vancomycin: should it be a concern?
    Balcı C; Uzun Ö; Arıcı M; Hayran SA; Yüce D; Ünal S
    Int J Antimicrob Agents; 2018 Aug; 52(2):180-184. PubMed ID: 29649586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of combining vancomycin with piperacillin/tazobactam or with meropenem on vancomycin-induced nephrotoxicity.
    Tookhi RF; Kabli NA; Huntul MA; Thabit AK
    Intern Emerg Med; 2021 Jun; 16(4):975-979. PubMed ID: 33439417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced nephrotoxicity with vancomycin therapeutic drug monitoring guided by area under the concentration-time curve against a trough 15-20 μg/mL concentration.
    Oda K; Jono H; Nosaka K; Saito H
    Int J Antimicrob Agents; 2020 Oct; 56(4):106109. PubMed ID: 32721597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Acute Kidney Injury With Concomitant Vancomycin and Piperacillin/Tazobactam Treatment Among Hospitalized Children.
    Downes KJ; Cowden C; Laskin BL; Huang YS; Gong W; Bryan M; Fisher BT; Goldstein SL; Zaoutis TE
    JAMA Pediatr; 2017 Dec; 171(12):e173219. PubMed ID: 28973124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vancomycin-Associated Acute Kidney Injury in a Large Veteran Population.
    Gyamlani G; Potukuchi PK; Thomas F; Akbilgic O; Soohoo M; Streja E; Naseer A; Sumida K; Molnar MZ; Kalantar-Zadeh K; Kovesdy CP
    Am J Nephrol; 2019; 49(2):133-142. PubMed ID: 30677750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Prevalence of Acute Kidney Injury in Chinese Patients Receiving Vancomycin with Concurrent β-Lactam Antibiotics: A Retrospective Cohort Study.
    Liu K; Zhang Y; Xu X; Wu B; Ni J; Li T; Xing C; Mao H
    Clin Ther; 2021 Oct; 43(10):e319-e351. PubMed ID: 34579971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute Kidney Injury Associated With Vancomycin When Laxity Leads to Injury and Findings on Kidney Biopsy.
    Katikaneni M; Lwin L; Villanueva H; Yoo J
    Am J Ther; 2016; 23(4):e1064-7. PubMed ID: 26035034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin-associated nephrotoxicity in non-critically ill patients admitted in a Brazilian public hospital: A prospective cohort study.
    de Almeida CDC; Simões E Silva AC; de Queiroz Oliveira JA; Batista ISF; Pereira FH; Gonçalves JE; Nobre V; Martins MAP
    PLoS One; 2019; 14(9):e0222095. PubMed ID: 31487314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supratherapeutic vancomycin levels after trauma predict acute kidney injury and mortality.
    Ley EJ; Liou DZ; Singer MB; Mirocha J; Srour M; Bukur M; Margulies DR; Salim A
    J Surg Res; 2013 Sep; 184(1):501-6. PubMed ID: 23731689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addition of Vancomycin to Cefazolin Prophylaxis Is Associated With Acute Kidney Injury After Primary Joint Arthroplasty.
    Courtney PM; Melnic CM; Zimmer Z; Anari J; Lee GC
    Clin Orthop Relat Res; 2015 Jul; 473(7):2197-203. PubMed ID: 25421958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrotoxicity during Vancomycin Therapy in Combination with Piperacillin-Tazobactam or Cefepime.
    Rutter WC; Cox JN; Martin CA; Burgess DR; Burgess DS
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27895019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of vancomycin AUC/MIC dosing vs traditional trough dosing and incidence of acute kidney injury at a rural community hospital.
    McClure S; McElroy L; Gugkaeva Z
    Am J Health Syst Pharm; 2024 May; 81(11):e283-e288. PubMed ID: 38253056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative incidence and excess risk of acute kidney injury in hospitalised patients receiving vancomycin and piperacillin/tazobactam in combination or as monotherapy.
    Carreno J; Smiraglia T; Hunter C; Tobin E; Lomaestro B
    Int J Antimicrob Agents; 2018 Nov; 52(5):643-650. PubMed ID: 30103003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute kidney injury during daptomycin versus vancomycin treatment in cardiovascular critically ill patients: a propensity score matched analysis.
    Gaudard P; Saour M; Morquin D; David H; Eliet J; Villiet M; Daures JP; Colson P
    BMC Infect Dis; 2019 May; 19(1):438. PubMed ID: 31109283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of serum concentration and concomitant drugs on vancomycin-induced acute kidney injury in haematologic patients: a single-centre retrospective study.
    Okada N; Chuma M; Azuma M; Nakamura S; Miki H; Hamano H; Goda M; Takechi K; Zamami Y; Abe M; Ishizawa K
    Eur J Clin Pharmacol; 2019 Dec; 75(12):1695-1704. PubMed ID: 31511938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.